Search

Your search keyword '"Bubley G."' showing total 157 results

Search Constraints

Start Over You searched for: Author "Bubley G." Remove constraint Author: "Bubley G."
157 results on '"Bubley G."'

Search Results

1. FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP)

2. Long-Term Patient-Reported Health-Related Quality of Life in the Randomized FORMULA-509 Trial of Salvage Radiotherapy and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate Plus Prednisone and Apalutamide after Radical Prostatectomy

3. Testosterone Recovery and Associated Impact on Patient-Reported Health-Related Quality of Life (HRQoL) after Treatment with 6 Months of GnRH Agonist with or without Abiraterone Acetate plus Prednisone (AAP) and Apalutamide (Apa) in the FORMULA-509 Trial

4. Subjective endpoints in clinical trials: the case for blinded independent central review

5. 637P Biochemical response (PSA0) and testosterone (T) recovery in Metacure, a multi-arm multi-modality (MM) therapy (tx) for very high risk localized (HRL) and low volume metastatic (LVM) prostatic adenocarcinoma

6. Oncogenic signaling pathways in the Cancer Genome Atlas

7. Erratum: The Immune Landscape of Cancer (Immunity (2018) 48(4) (812–830.e14), (S1074761318301213), (10.1016/j.immuni.2018.03.023))

11. The Molecular Taxonomy of Primary Prostate Cancer

14. 2501 ORAL A randomized, open-label, phase 2 study of enzalutamide as neoadjuvant therapy for patients undergoing prostatectomy for localized prostate cancer

30. A Phase II study of the safety, pharmacokinetics and efficacy of IncelTM (biricodar, VX-710) in combination with mitoxantrone (M) and prednisone (P) in advanced hormone refractory prostate cancer (HRPC)

35. Her-2-neu expression and progression toward androgen independence in human prostate cancer.

36. Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation.

37. Combination of etanidazole with cyclophosphamide and platinum complexes.

39. Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions

41. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and mutagenesis of herpes simplex virus type 1

42. Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle.

47. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

48. A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples

49. Comprehensive Characterization of Cancer Driver Genes and Mutations

50. Genomic and functional approaches to understanding cancer aneuploidy

Catalog

Books, media, physical & digital resources